Generation and characterization of an ABCC1 humanized mouse model (HABCC1FLX/FLX) with knockout capability

Markus Krohn, Viktoria Zoufal, Severin Mairinger, Thomas Wanek, Kristin Paarmann, Thomas Brüning, Ivan Eiriz, Mirjam Brackhan, Oliver Langer, Jens Pahnke*

*Corresponding author for this work

Abstract

ATP-binding cassette (ABC) transporters such as ABCB1 (P-glycoprotein), ABCC1 (MRP1), and ABCG2 (BCRP) are well known for their role in rendering cancer cells resistant to chemotherapy. Additionally, recent research provided evidence that, along with other ABC transporters (ABCA1 and ABCA7), they might be cornerstones to tackle neurodegenerative diseases. Overcoming chemoresistance in cancer, understanding drug-drug interactions, and developing efficient and specific drugs that alter ABC transporter function are hindered by a lack of in vivo research models, which are fully predictive for humans. Hence, the humanization of ABC transporters in mice has become a major focus in pharmaceutical and neurodegenerative research. Here, we present a characterization of the first Abcc1 humanized mouse line. To preserve endogenous expression profiles, we chose to generate a knockin mouse model that leads to the expression of a chimeric protein that is fully human except for one amino acid. We found robust mRNA and protein expression within all major organs analyzed (brain, lung, spleen, and kidney). Furthermore, we demonstrate the functionality of the expressed human ABCC1 protein in brain and lungs using functional positron emission tomography imaging in vivo. Through the introduction of loxP sites, we additionally enabled this humanized mouse model for highly sophisticated studies involving cell type-specific transporter ablation. Based on our data, the presented mouse model appears to be a promising tool for the investigation of cell-specific ABCC1 function. It can provide a new basis for better translation of preclinical research.

Original languageEnglish
JournalMolecular Pharmacology
Volume96
Issue number2
Pages (from-to)138-147
Number of pages10
ISSN0026-895X
DOIs
Publication statusPublished - 2019

Funding

The establishment of the mice was financially supported by Immunge-netics AG (Rostock, Germany). The mice are available to researchers at nonprofit organizations without restrictions against a one-time contribution to help maintaining the strain. The work of J.P. was financed by Deutsche Forschungsgemeinschaft/Germany [Grants PA930/9 and PA930/12]; Wirt-schaftsministerium Sachsen-Anhalt/Germany [Grant ZS/2016/05/78617]; the Leibniz Association, Leibniz-Wettbewerb [Grant SAW-2015-IPB-2]; Latvian Council of Science/Latvia [Grant lzp-2018/1-0275]; HelseSØ/ Norway [Grants 2016062, 2019054, and 2019055]; Norsk Forskningsrådet/ Norway [Grants 251290 (FRIMEDBIO) and 260786 (PROP-AD)]; and Horizon 2020/European Union [Grant 643417 PROP-AD]. The work of O.L. and T.W. was financed by the Austrian Science Fund [Grant I 1609-B24 (to O.L.)], and the Lower Austria Corporation for Research and Education [Grant LS14-008 (to T.W.)]. PROP-AD is a European Union Joint Programme–Neurodegenerative Disease Research (JPND) project. The project is supported through the following funding organizations under the aegis of JPND [www.jpnd.eu; (Academy of Finland [AKA] Grant 301228 (Finland), Bundesministerium fur Bildung ünd Forschung [BMBF] Grant 01ED1605 (Germany), Chief Scientific Office of the Israeli Ministry [CSO-MOH] Grant 30000-12631 (Israel), Norges Forskningsradet/Norwegian Research Council [NFR] Grant 260786 (Norway), and Swedish Research Council [SRC] Grant 2015-06795 (Sweden)]. This project has received funding from the European Union’s Horizon 2020 research and innovation program [Grant 643417 (JPco-fuND, co-funded initiative between JPND and the European Commission)]. J.P. is shareholder of Immungenetics AG.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Fingerprint

Dive into the research topics of 'Generation and characterization of an ABCC1 humanized mouse model (HABCC1FLX/FLX) with knockout capability'. Together they form a unique fingerprint.

Cite this